EUVIMEDEUVIMED entdecken
Fallbericht

Pathogenesis‐directed treatment of linear porokeratosis with topical cholesterol‐lovastatin

Hasina Maredia, Jennifer L Hand, Megha M Tollefson

Pediatric Dermatology · 2024

DOI: 10.1111/pde.15427 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pediatric Dermatology, 2024. Verfasst von Hasina Maredia und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Lovastatin, Porokeratosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A 2‐year‐old boy presented with an extensive, asymptomatic, photosensitive eruption refractory to topical steroids and tretinoin; examination and biopsies were consistent with generalized linear porokeratosis involving the face, limbs, and trunk. Treatment with topical cholesterol‐lovastatin was initiated, and it successfully improved early erythematous lesions. Whole exome sequencing that targeted mevalonate pathway genes crucial in cholesterol synthesis later revealed a pathogenic, paternally inherited, porokeratosis‐associated MVD , c.70+5 G>A, mutation. Topical cholesterol‐lovastatin is a safe and effective empiric treatment for porokeratosis when used in the early, erythematous phase, and its success is likely mediated through its role in targeting mevalonate pathway mutations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LovastatinPorokeratosisChild, PreschoolHumansMaleCholesterolMevalonic AcidTreatment Outcome

Stichwörter der Autor:innen

cholesterol-lovastatin lotionporokeratosistargeted therapy

Substanzen

CholesterolLovastatinMevalonic Acid

Autor:innen und Institutionen

  • Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Clinical Genomics, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Pediatrics, Jacobs School of Medicine, Buffalo, New York, USA.

Zitieren

APA

Maredia, H., Hand, J. L., & Tollefson, M. M. (2024). Pathogenesis‐directed treatment of linear porokeratosis with topical cholesterol‐lovastatin. Pediatric Dermatology. https://doi.org/10.1111/pde.15427

Vancouver

Maredia H, Hand JL, Tollefson MM. Pathogenesis‐directed treatment of linear porokeratosis with topical cholesterol‐lovastatin. Pediatric Dermatology. 2024. doi:10.1111/pde.15427

BibTeX
@article{Maredia2024,
  author = {Maredia, Hasina and Hand, Jennifer L and Tollefson, Megha M},
  title = {Pathogenesis‐directed treatment of linear porokeratosis with topical cholesterol‐lovastatin},
  journal = {Pediatric Dermatology},
  year = {2024},
  doi = {10.1111/pde.15427}
}
Kostenlos starten →